Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q3 2023 Earnings Presentation
7 slides from Aurora Cannabis's earnings presentation, Jun 14, 2023
Slide 1: Fiscal Q3 2023 Supplemental Information
FISCAL Q3 2023 SUPPLEMENTAL INFORMATION JUNE 2023
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Key Takeaways
Key Takeaways Opening the Remain #1 Canadian LP in global medical cannabis revenues World to Significant growth opportunities in high margin domestic and international medical cannabis segments Cannabis Achieved Adjusted EBITDA profitability for two consecutive quarters, ending December 31, 20
Slide 4: FY23 Q3 Key Financial Highlights
FY23 Q3 Key Financial Highlights • Consolidated Results • Adjusted EBITDA (1) was 0.3 million in Q3, the second sequential quarter of positive adjusted EBITDA, and an increase of $10.3 million compared to the same period of the prior year. The increase is primarily attributable to revenue growth, th
Slide 5: Year-over-Year Financial Trends
Year-over-Year Financial Trends Metric FY23 Q3 FY22 Q3 YoY Movement (%) Total cannabis net revenue (1) $53.3m $50.4m 6% Adjusted Gross Profit Before $30.6m $27.3m 12% Fair Value Adjustments (1) Adjusted SG&A (1)(2) $28.4m $35.6m 20% Adjusted EBITDA(1) $0.3m ($10.0m) 103% Cash Used in Operations $15.
Slide 6: Sequential Quarter Trends
Sequential Quarter Trends Metric FY23 Q3 FY23 Q2 QoQ Movement (%) Total cannabis net revenue (1) $53.3m $55.0m 3% Plant propagation net revenue (1) $10.8 $6.6m 64% Adjusted Gross Profit Before $30.6 $27.6m 11% Fair Value Adjustments (1) Adjusted SG&A (1)(2) $28.4m $25.4 12% Adjusted EBITDA(1) $0.3m
Slide 7: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: auroramj.com/investors